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The t*5I-labeled M, 80 000 form of neurophysin has been purified from bovine neurohypophysi. Tryptic 
digests of this species were analyzed, prior to or after treatment with carboxypeptidase B, by high-pressure 
liquid chromatography followed by isoelectric focusing and the fragments compared with those generated 
by a similar treatment of reference bovine 1-39 adrenocorticotropin. The ACTH peptides 22-39 and l-8, 
as well as the 1-7 derivative of the latter were identified by those two independent criteria. This provides 
chemical evidence supporting the hypothesis [8] that high M, neurophysin may contain the sequence of 
ACTH. 
Corticotropin Neuroph ysin Neuropeptide precursor 
High-performance liquid chromatography _ 
1. INTRODUCTION 
A body of evidence now indicates that both neu- 
rophysin and A$-vasopressin are synthesized in 
hypothalamic neurons via an M, 17 000-20 000 
common precursor [l-5]. Moreover, the sequence 
of a cloned cDNA has been shown to code for a 
gene product of Mr 17 300 containing both neu- 
rophysin and vasopressin [5]. However, analysis of 
extracts of bovine hypothalamus or neurohy- 
pophysis [3,6] as well as of lysates made from neu- 
rosecretory granules [7] from the same organ, indi- 
cate that they contain in addition to the M, 
17 000-20 000 molecules, species of Mr 80 000 
bearing both neurophysin and vasopressin anti- 
genie determinants and resistant both to denatura- 
tion and to disulfide-bridge reduction [6]. Tryptic 
peptide analysis of a fragment derived from this 
molecule established sequence homologies with 
neurophysin [6]. This large species indeed cross- 
Abbreviations: SDS, sodium dodecyl sulfate; CPB, car- 
boxypeptidase B; DFP, diisopropylfluorophosphate; 
ACTH, adrenocorticotropin hormone; HPLC, high-per- 
formance liquid chromatography; IEF, isoelectric focus- 
ing; PI, isoelectric point 
Tryptic peptide mapping Hypothalamus 
reacts both with anti-corticotropin and anti-/& 
endorphin antibodies and generates biologically 
active corticotropin by proteolysis [8]. Therefore it 
might include in its structure the sequences of 
these neuropeptides; in [8] it was proposed as a 
new example of pluripotent pro-hormone. 
Here we show that this type of high M, neuro- 
physin called coenophorin [8] (from the Greek 
Koivos = common and $EPW = I bear) indeed pos- 
sesses equences tretches homologous to the N- 
and C-terminal sequences of ACTH. 
2. METHODS 
2.1. Purification of 1251~labeled coenophorin 
The labeled M, 80 000 form of neurophysin was 
purified to homogeneity as in [6]. Briefly, partially 
purified high M, immunoreactive species from 
bovine neurohypophysis were labeled with 1251 
and immunoprecipitated with antibodies directed 
against bovine neurophysin II. Labeled antibody- 
bound material was solubilized by boiling in 
62.5 mM Tris-HCl (pH 6.8) containing 10% 
glycerol, 5% mercaptoethanol and 2% SDS for 
5 min and then submitted to SDS-polyacrylamide 
gel electrophoresis [6]. The Mr 80 000 species was 
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detected by autoradiography, cut out and digested 
with trypsin as in [6]. 
2.2. Identification of ACTHpeptides 
Tryptic peptides derived from ACTH were iden- 
tified in the digest by comparing both their reten- 
tion time, in reverse-phase, high-pressure liquid 
chromatography (HPLC), and their isoelectric 
point (PI) with those of reference peptides derived 
from t2sI-labeled standard bovine ACTH l-39. 
Cleavage with carboxypeptidase B: Tryptic pep- 
tides recovered from the M, 80 000 species or from 
l-39 ACTH were further treated with 0.1 PLg por- 
cine carboxypeptidase B (DFP-treated, Sigma, St 
Louis MO) in 200 ~1 0.1 M ammonium bicarbo- 
nate for 1 h at 37°C and the reaction stopped by 
10 min boiling. 
High-performance liquid chromatography: Peptides 
derived from the *251-labeled M, 80 000 form of 
neurophysin or from 1251-labeled bovine l-39 
ACTH were taken up in H20: MeOH, 50:50 (v/v) 
and injected on a Cts p-Bondapack column (Wa- 
ters Assoc.). The column was eluted with an 
increasing i:roportion of I-propanol (O-30%) 
in aqueous trifluoroacetic acid (l/ 1000) at la flow 
rate of 1 ml/min. Each 1 min fraction was counted 
for 1251-radioactivity. 
Isoelectric focusing: Peptides recovered from 
HPLC fractionation were focused on 12%, ultra- 
thin (0.5 mm), polyacrylamide gels. A pH gradient 
9.5-3.5 or 5-3.5 was used (ampholines, LKB, Up- 
psala). The gels were dried and the radioactive 
peptides detected by autoradiography as in [6]. 
3. RESULTS 
The sequence of bovine ACTH [9] predicts 2 
tryptic peptides bearing a tyrosine residue which 
could be labeled with 1251: the N-terminal peptide 
from residues l-8; the C-terminal peptide from 
residues 22-39. Each one represents < l--2% of a 
Mr 80000 polypeptide chain. Peptide l-8 should 
be observed if it is either N-terminal or preceded 
by a basic amino acid in the sequence of high-M, 
neurophysin. Peptide 22-39 ends with a 
phenylalanine; it is thus unlikely to be found in a 
tryptic digest of high-M, neurophysin unless it is 
located at the C-terminal end. However, if it is fol- 
lowed, in the M, 80 000 species, by a basic amino 
acid residue (as it is the case in another high-M, 
form of ACTH, pro-opiomelanocortin) [10,111, it
should be possible to generate the corresponding 
peptide by treating a tryptic digest with carboxy- 
peptidase B (CPB) in order to remove the extra 
basic amino acid at its C-terminal end. Compari- 
son (not shown) of the labeled fragments obtained 
by tryptic digestion of reference ACTH l-39 and 
l-24, respectively, indicated unambiguously that 
the C-terminal peptide corresponds to the species 
with a retention time of 58 min (seen in tig.lA). 
The tryptic fragments recovered in the 30-40 min 
region were found in both cases and are common 
to ACTH 1-24 and l-39. Therefore, they corre- 
spond to the N-terminal region of ACTH (not 
shown). Microheterogeneity was observed, possi- 
bly due either to complex iodination reaction or 
incomplete proteolytic cleavage, or both. But a 
predominant peak was obtained eluting at 32 min 
(tig.lA) and probably corresponding to t251- 
ACTH l-8. Analysis of the tryptic digest of pu- 
rified M, 80 000 neurophysin prior to treatment 
with CPB showed the presence of a peptide with 
the same HPLC-chromatographic properties and 
p1 as ACTH 1-8 (tig.lA; fig. lB, lanes b,c). 
If the tryptic peptides are treated with CPB any 
fragment ending with either a lysine or arginine 
should be modified by loss of the C-terminal resi- 
due. After treatment with CPB the ACTH l-8 ref- 
erence peptide was shifted toward longer retention 
time on HPLC and lower p1 (tig.2A; tig.2B, lanes 
a,d); as expected, ACTH 22-39, ending with a 
phenylalanine residue, remained unaffected 
(tig.lA,2A). Treatment of the tryptic digest of high 
M, neurophysin with CPB generated a peptide 
with the same HPLC-retention time and p1 as the 
CPB-treated N-terminal sequence of ACTH 
(tig.ZA; tig.ZB, lanes c-e). Similarly, the CPB- 
treated tryptic digest of M, 80 000 form of neu- 
rophysin contains a set of peptides identified in a 
similar way to ACTH 22-39 (fig.2A; tig.2C, lanes 
c-e). 
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Fig. 1. Analysis of t**I tryptic peptides from the M, 
80000 form of neurophysin, by reverse-phase HPLC 
followed by IEF on polyacrylamide gels. High M, im- 
munoreactive species were analysed on a SDS-poly- 
acrylamide gel under reducing conditions, after t2%la- 
beling and immunoprecipitation by bovine anti- 
neurophysin antibodies, as in section 2. The’ M, 80 000 
band was located on a dried gel by autoradiography, cut 
out and treated with trypsin [6]. 
(A) Reverse phase HPLC: 
The tryptic peptides recovered after digestion of the M, 
80 000 species were first analyzed on a Cts I-Bondapack 
column (Waters Assoc.) (-•-). Tryptic peptides derived 
from t**I-labeled bovine l-39 ACTH were analyzed 
under the same conditions (oM). The arrow indicates 
the elution peak corresponding to the N-terminal por- 
tion l-8 of reference t251-ACTH. 
(B) Isoelectric focusing on polyacrylamide gels: 
Each fraction of the M, 80 000 digests eluted in the rele- 
vant regions of the HPLC separation was analyzed by 
isoelectric focusing on polyacrylamide gels, together 
with reference ACTH peptides. A pH gradient from 
9.5-3.5 (top to bottom) was used in this case. Lane: (b) 
fraction 32 min of the HPLC separation of trypsinized 
t251-ACTH; (a,c,d) fractions 31, 32 and 33 min. respec- 
tively of the HPLC separation of trypsinized M, 80 000 
t*sI-neurophysin. The arrows point to the radioactive 
peptide, with the same pI as the reference tryptic frag- 
ment 1-8 of t2sI-ACTH, which appears predominantly 
in fraction 32 min and was not detected in the fractions 
immediately preceeding and following this region of the 
chromatogram. 
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4. DISCUSSION 
Thus, we have identified by two independent 
criteria the ACTH peptides 22-39 and l-8 as well 
as the l-7 derivative of the latter. This provides 
chemical evidence supporting the hypothesis that 
high h4, neurophysin may contain the sequence of 
ACTH [8]. Since, on the other hand, vasopressin- 
and /I-endorphin-like immunoreactivities also 
copurify with this species [8], it appears that this 
very large form of neurophysin is, indeed, a com- 
posite molecule. 
The presence of the M, 80 000 form of neu- 
rophysin is now firmly established on chemical 
grounds. Observations by others of M, 80 000 form 
of immunoactive AVP (A. Cupo and M. Delaage, 
unpublished) and Mr 3 70 000 of neurophysin and 
vasopressin in extracts of rat hypothalamo-neu- 
rohypophyseal system [ 121 support this contention. 
In this respect, it is of interest that biosynthetic 
studies of ectopic vasopressin production in a lung 
carcinoma showed incorporation of 3sS-label in an 
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Fig.2. Analysis of the 1251 peptides generated by trypsin- 
ization of the M, 80 000 form of neurophysin followed 
by treatment with carboxypeptidase B (CPB). Tryptic 
peptides derived from M, 80 000 form of neurophysin or 
from reference 1-39 ACTH were first submitted to CPB 
and then analyzed as in fig. 1. 
(A) HPLC patterns of the Mr 80 000 digest (-•-) and of 
standard labeled ACTH processed under the same con- 
ditions (0~). Arrows indicate fractions 36 and 58 min 
corresponding, respectively to fragments l-7 and 22-39 
of “-51-ACTH. 
abcdef 
(B) IEF analysis (pH 9.5-3.5; top-to-bottom) of mat- 
erial recovered under fractions 35-38 min (lanes b,c,e 
and f, respectively) of the HPLC separation of the M, 
80 000 digest. Lane d represents fractions 36 min of the 
HPLC separation of reference t251-ACTH treated by 
trypsin + CPB. Lane a (double arrow) is fragment 1-8 
untreated by CPB (seen also in fig.lB, lane b). Arrows 
point to radioactive peptide with the same p1 as the 
reference fragment 1-7 of t251-ACTH. 
(C) IEF analysis (pH 5.0-3.5; top-to-bottom) of the ma- 
terial recovered under fractions 56-60 min (lanes 
a,b,d,e and f, respectively) of Iig.ZA (-•-). Lane c shows 
the material of fraction 58 min (fig.ZA (,*.). The arrows 
point to a set of peptides corresponding to the 
C-terminal fragment 22-39 of t2sI-ACTH. 
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immunoreactive material larger than the predomi- 
nant Mr 20 000 species [ 131. It is not clear as yet 
whether these species are related to each other. 
However, none can be accounted for by the se- 
quence of the M, 17 300 neurophysin-vasopressin 
precursor predicted from the cloned cDNA 
characterized in (51. Therefore, it is not unexpected 
that such large molecules might harbour the se- 
quences of several, additional, biologically active 
peptides. 
Relationships between the M, 80 000 coeno- 
phorin, pro-opiocortin and pro-neurophysin-vas- 
opressin remain to be established. As suggested in 
[3,6], these molecules may derive from distinct 
genes. Alternatively, they might arise either from 
differently arranged DNA sequences or from dif- 
ferently spliced mRNA. The biological function of 
coenophorin is still unknown. It is tempting to 
speculate that it may represent the common store- 
house of a set of neuropeptides elaborated in spe- 
cialized neurons of the hypothalamus. Anyway, it 
seems hardly compatible with the so-called ‘one 
neuron-one hormone’ theory [14]. The presence 
of several neuropeptide sequences on the same 
high-Mr form may provide a unitary explanation 
to a number of cytoimmunological observations 
which strongly argue in favor of the concomitant 
and ubiquitous presence of several immunoreac- 
tive peptides in the same neurons [ 15- 171: in par- 
ticular to the detection of ACTH and /?-endorphin 
immunoreactivities in neurons belonging to the 
magnocellular system of the rat hypothalamus 
[ 18,191. 
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